Back to Atlas
BSemi-durableStandard research/education caution
CMP-0246
Approved/Research
Tropisetron
Cholinergic / Serotonergic
Cognition and sensory-gating positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- 5-HT3 antagonist and alpha7 nicotinic activity
- Primary market use
- Cognition/GI
Pharmacology
- Molecular weight (Da)
- 284.4
- Oral bioavailability
- ~60-80%
- Half-life
- ~8 h
- Route tags
- Route-dependent / verify
- Evidence level
- Approved some markets
- Clinical status
- Approved/Research
- Value-for-money score
- 6 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Cognitive effect primarily pharmacologic; placed B/C border